(Press-News.org) The swift development of vaccines has provided a vital tool to combat the spread of the deadly SARS-CoV-2 virus, but challenges to reaching herd immunity posed by the rise of new mutations and the inability of immunosuppressed people to develop an effective immune response following vaccination point to a need for additional solutions to maximize protection.
A new USC study published in the Journal of Biological Chemistry reveals how therapies targeting a molecular chaperone called GRP78 might offer additional protection against COVID-19 and other coronaviruses that emerge in the future.
Chaperones like GRP78 are molecules that help regulate the correct folding of proteins, especially when a cell is under stress. But in some cases, viruses can hijack these chaperones to infect target cells, where they reproduce and spread. GRP78 has been implicated in the spread of other serious viruses, such as Ebola and Zika.
GRP78 plays more than one role in COVID-19
While studies have shown that SARS-CoV-2, the virus that causes COVID-19, infects cells by binding with ACE2 receptors on their surface, researchers from the Keck School of Medicine of USC examined whether GRP78 has a role as well.
They found that GRP78 serves as a co-receptor and stabilizing agent between ACE2 and SARS-CoV-2, enhancing recognition of the virus' spike protein and allowing more efficient viral entry into host cells.
This study provides the first experimental evidence in support of computer modeling predictions, demonstrating that GRP78 binds the Spike protein of SARS-CoV-2 in cells. Interestingly, computer modeling further shows that COVID-19 variants that are more infectious bind stronger to GRP78.
Additionally, the research team found that GRP78 also binds to and acts as a regulator of ACE2 - bringing the protein to the cell surface, which offers SARS-CoV-2 more points to bind with and infect cells.
"Our study reveals that therapy targeting GRP78 could be more effective at protecting and treating people who contract COVID-19 than vaccines alone, particularly when it comes to people who can't get the vaccine and variants that could bypass vaccine protection but still depend on GRP78 for entry and production," said senior author Amy S. Lee, PhD, Judy and Larry Freeman Chair in basic science research and professor at the department of biochemistry & molecular medicine at the Keck School of Medicine of USC.
How SARS-CoV-2 hijacks GRP78
GRP78's job as a chaperone molecule is to fold proteins in the endoplasmic reticulum (ER), which is a protein production factory. Upon stress, including stress caused by SARS-CoV-2 infection, GRP78 is shipped out to the cell surface. There, it facilitates binding between ACE2 and Spike protein of SARS-CoV-2, leading to enhanced viral entry. Once inside the cell, viruses are known to hijack the ER protein folding machinery, of which GRP78 is a key player, to produce more viral proteins.
This process can be intensified in cells under stress from other diseases like diabetes or cancer, which may be one of the reasons people who have underlying health conditions are more susceptible to SARS-CoV-2 infection.
To investigate the role of GRP78 in SARS-CoV-2 infection, researchers treated lung epithelial cells with humanized monoclonal antibody (hMAb159), known to remove GRP78 from the cell surface with no adverse effects in mouse models. Intervention removed GRP78 and reduced ACE2 on the cell surface, diminishing the number of targets to which SARS-CoV-2 could attach.
These findings led researchers to conclude that interventions, such as hMAb159, to remove cell surface GRP78 could reduce SARS-CoV-2 infection and inhibit the spread and severity of COVID-19 in people who are infected.
Potential for GRP78 targeted treatment
Healthy cells need a fraction of GRP78 to function normally. However, stressed cells, such as virally infected or cancerous cells, need more GRP78 to survive and multiply, so treatments that reduce the amount of GRP78 in the body could reduce the severity of SARS-CoV-2 infection and spread without adverse effects.
While this study used a monoclonal antibody, researchers say there are other agents that could be used to reduce the amount or activity of GRP78, creating multiple pathways for potential drug solutions to target GRP78.
"What is particularly exciting for this finding is that GRP78 could be a universal target in combination with existing therapies not just to combat COVID-19, but other deadly viruses that depend on GRP78 for their infectivity as well," said Lee.
The next step for the research team is to explore these findings further through animal studies.
INFORMATION:
About the study
This study was a collaborative effort among expert researchers across basic sciences, virology and experimental therapeutics. Researchers utilized USC's Biosafety-Level 3 containment laboratory, allowing them to safely study the role of GRP78 on SARS-CoV-2 infection using live virus cultures.
In addition to Lee, the study's authors include Parkash Gill, MD, of the department of medicine; Keigo Machida, PhD, and Da-Wei Yeh, PhD, of the department of molecular microbiology & immunology; and lead author Anthony Carlos, PhD, Dat Ha, Richard Van Krieken, PhD, Chun-Chih Tseng, PhD, and Pu Zhang of the department of biochemistry & molecular medicine.
This study was supported with grants from the National Institute of Health (R01 CA027607, R01 CA238029, R01 CA027607-37S1, R01 AA025204-01A1, R21 AA025470-01A1 and P50 AA11999) and a pilot grant from a gift by the W. M. Keck Foundation to support COVID-19 research.
About Keck School of Medicine
Founded in 1885, the Keck School of Medicine of USC is one of the nation's leading medical institutions, known for innovative patient care, scientific discovery, education, and community service. Medical and graduate students work closely with world-renowned faculty and receive hands-on training in one of the nation's most diverse communities. They participate in cutting-edge research as they develop into tomorrow's health leaders. With more than 900 resident physicians across 50 specialty and subspecialty programs, the Keck School is the largest educator of physicians practicing in Southern California.
Reduced levels of a metabolic hormone known as leptin is linked to poor vaccine antibody responses in the general population, a University of Queensland study has found.
The researchers made the discovery while investigating several cohorts' responses to the influenza vaccine or hepatitis B vaccine pre-COVID.
UQ's Professor Di Yu identified a link between the metabolic and immune systems that could be used to develop new strategies for improving vaccine protection in vulnerable populations.
"Using multiple advanced techniques in immunology, genetics ...
Women taking 1,000 mg of docosohexanoic acid (DHA) daily in the last half of pregnancy had a lower rate of early preterm birth than women who took the standard 200 mg dose, according to a study funded by the National Institutes of Health. Women who entered the study with the lowest DHA level had the greatest reduction in early preterm birth, which is birth before 34 weeks of pregnancy and which increases the risk of infant death and disability
The study was conducted by Susan E. Carlson, Ph.D., at the University of Kansas Medical Center, Kansas City, and colleagues. It appears in EClinicalMedicine. Funding was provided by NIH's Eunice Kennedy Shriver National ...
Among the powerful biochemicals of the human immune system, peptides are one of the best.
Most commonly found in the places where microbes love to take root - mucous membranes of the eye, mouth, nose and lungs - they're known to kill all sorts of tiny invaders, such as viruses, bacteria and fungi.
Given their power, one might think peptides would represent promising drug treatments, perhaps even a cure, for many infectious diseases. But, alas, they are fundamentally flawed: They are vulnerable to a myriad of enzymes whose job is to rapidly break them down in a way that robs them of their therapeutic properties.
"Because of their vulnerability to enzymatic breakdown, ...
A clinical study led by Linköping University and financed by pharmaceuticals company Diamyd Medical has investigated whether immunotherapy against type 1 diabetes can preserve the body's own production of insulin. The results suggest that injection of a protein, GAD, into lymph nodes can be effective in a subgroup of individuals. The results have been published in Diabetes Care.
In type 1 diabetes, the body's immune system attacks the cells that produce insulin. When the insulin-producing cells have disappeared, the body can no longer regulate blood sugar level, and a person with type 1 diabetes must take exogenous ...
Regular, standardized assessments of evacuation shelters can help keep people healthy following natural disasters, according to research published by Tohoku University scientists and colleagues in the journal Heliyon. The study found that a clean tap water supply and hygienic toilets were especially important for protecting evacuees from the spread of infectious diseases.
"A clean water supply and maintaining hygiene are important for reducing environmental health risks among victims of natural disasters," says Tadashi Ishii, who specializes in disaster medicine at Tohoku University. "But scientists have
not yet established a strong evidence base that describes the relationship between damage in resource supplies and infrastructure ...
HOUSTON - (May 24, 2021) - U.S. and Austrian physicists searching for evidence of quantum criticality in topological materials have found one of the most pristine examples yet observed.
In an open access paper published online in Science Advances, researchers from Rice University, Johns Hopkins University, the Vienna University of Technology (TU Wien) and the National Institute of Standards and Technology (NIST) present the first experimental evidence to suggest that quantum criticality -- a disordered state in which electrons waver between competing states of order -- may give rise to topological phases, "protected" quantum states that are of growing interest ...
A diverse microbial community has adapted to an extremely salty environment deep in the Red Sea. The microbes, many unknown to science, occupy a one-meter-thick area overlying the Suakin Deep, an expansive 80-meter-deep brine lake, 2,771 meters below the central Red Sea. The chemical properties of this thin "brine-seawater interface," along with the composition of microbial communities, change surprisingly rapidly across a sharp gradient.
"Our study sheds light on how microorganisms in the Suakin Deep's brine-seawater interface make an oasis of life in the desert of the deep Red Sea," says microbial ...
Osaka, Japan - Scientists from the Institute of Scientific and Industrial Research, and NTN Next Generation Research Alliance Laboratories at Osaka University developed a machine learning method that combines convolutional neural networks and Bayesian hierarchical modeling to precisely predict the remaining useful life of rolling bearings. This work may lead to new industrial monitoring methods that help manage maintenance schedules and maximize efficiency and safety under defect progression.
A rolling bearing consists of two rings separated by rolling elements (balls or rollers). Because of the ease of rolling, the rings can rotate relative to each other with very little friction. Rolling bearings are essential to almost all automated machinery with rotating elements. The bearings ...
Scientists used to perform experiments by stirring biological and chemical agents into test tubes.
Nowadays, they automate research by using microfluidic chips the size of postage stamps. In these tiny devices, millions of microscopic particles are captured in droplets of water, each droplet serving as the "test tube" for a single experiment. The chip funnels these many droplets, one at a time, through a tiny channel where a laser probes each passing droplet to record thousands of experimental results each second.
These chips are used for such things as testing new antibiotics, screening drug compounds, sequencing the DNA and RNA of single cells, and otherwise speeding up the pace of scientific ...
Three dozen dwarf galaxies far from each other had a simultaneous "baby boom" of new stars, an unexpected discovery that challenges current theories on how galaxies grow and may enhance our understanding of the universe.
Galaxies more than 1 million light-years apart should have completely independent lives in terms of when they give birth to new stars. But galaxies separated by up to 13 million light-years slowed down and then simultaneously accelerated their birth rate of stars, according to a Rutgers-led study published in the Astrophysical Journal.
"It appears that these galaxies are responding to a large-scale ...
